Will Ashworth

Will Ashworth

InvestorPlace Contributor

Expertise: Public and private companies, Portfolio construction

About Will:
Will Ashworth has written about investments full-time since 2008. He loves investing and is passionate about helping others put their money to work. He particularly enjoys creating model portfolios that stand the test of time.

Publications where he’s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He lives in Halifax, Nova Scotia.

You can follow Will on LinkedIn. 

Recent Articles

Food Fight: Why Kellogg Stock Beats General Mills

By Will Ashworth, InvestorPlace Contributor

If Kellogg (K) looks a little dirtier than General Mills (GIS), it's because of all the hard work the company is putting into strengthening its business.

Take a Break from Hess, Pick Up Marathon

By Will Ashworth, InvestorPlace Contributor

While Hess and Marathon Oil had tough third quarters, one company's recent oil-field acquisitions bode well. See which stock is the better buy.

CF Industries Sows the Seeds of Interest

By Will Ashworth, InvestorPlace Contributor

Agricultural biotech specialist Monsanto (MON) is reliable, but fertilizer company CF Industries (CF) is much better poised for growth.

Betting on the Recovery? Back Paychex, Skip ADP

By Will Ashworth, InvestorPlace Contributor

Not everyone will ride economic recovery the same way -- Paychex's (PAYX) ability to make more with less, as well as its dividend, make it more attractive.

MAKO Surgical Has Promising Potential

By Will Ashworth, InvestorPlace Contributor

More than a decade after its IPO, Intuitive Surgical (ISRG) remains healthy, but newcomer MAKO Surgical (MAKO) is primed for growth.

Caterpillar or Joy Global: Which Should You Dig Into?

By Will Ashworth, InvestorPlace Contributor

If you want a pure-play mining-equipment maker, the answer is easy. A big difference in debt helps make the decision even easier.

Jump Into Walgreen on the Cheap; Ditch CVS

By Will Ashworth, InvestorPlace Contributor

Walgreens (WAG) might actually benefit from a breakup with Express Scripts, and its standing as a Dividend Aristocrat doesn't hurt its case, either.

What Jim Rogers Might Say About October’s Market Rally

By Will Ashworth, InvestorPlace Contributor

Here's a look at what the iconic investor might be thinking about October's bull run, as well as what investors should expect looking forward.

Ringing Up Brazil’s Biggest Telecom Player

By Will Ashworth, InvestorPlace Contributor

More than Siemens AG (SI), Tele Norte Leste Participacoes' (TNE) best days are ahead of it.

Bank of Nova Scotia a Better Northern Neighbor than TD Bank

By Will Ashworth, InvestorPlace Contributor

Bank of Nova Scotia's (BNS) reach into emerging markets, rather than a reliance on a competitive U.S. market, makes it a more attractive play than TD Bank (TD).

Load More